These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 33606316)

  • 1. Single-center utilization of donor-derived cell-free DNA testing in the management of heart transplant patients.
    Gondi KT; Kao A; Linard J; Austin BA; Everley MP; Fendler TJ; Khumri T; Lawhorn SL; Magalski A; Nassif ME; Sperry BW; Vodnala D; Borkon AM
    Clin Transplant; 2021 May; 35(5):e14258. PubMed ID: 33606316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiation of noninvasive surveillance for allograft rejection in heart transplant patients > 1 year after transplant.
    Kewcharoen J; Kim J; Cummings MB; Leitner KB; Suzuki EMB; Banerjee D; Lum CJ
    Clin Transplant; 2022 Mar; 36(3):e14548. PubMed ID: 34843112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantation.
    Kim PJ; Olymbios M; Siu A; Wever Pinzon O; Adler E; Liang N; Swenerton R; Sternberg J; Kaur N; Ahmed E; Chen YA; Fehringer G; Demko ZP; Billings PR; Stehlik J
    J Heart Lung Transplant; 2022 Jul; 41(7):919-927. PubMed ID: 35577713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance with dual noninvasive testing for acute cellular rejection after heart transplantation: Outcomes from the Surveillance HeartCare Outcomes Registry.
    Khush K; Hall S; Kao A; Raval N; Dhingra R; Shah P; Bellumkonda L; Ravichandran A; Van Bakel A; Uriel N; Patel S; Pinney S; DePasquale E; Baran DA; Pinney K; Oreschak K; Kobulnik J; Shen L; Teuteberg J
    J Heart Lung Transplant; 2024 Sep; 43(9):1409-1421. PubMed ID: 38759766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early findings after integration of donor-derived cell-free DNA into clinical care following pediatric heart transplantation.
    Feingold B; Rose-Felker K; West SC; Zinn MD; Berman P; Moninger A; Huston A; Stinner B; Xu Q; Zeevi A; Miller SA
    Pediatr Transplant; 2022 Feb; 26(1):e14124. PubMed ID: 34420244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two donor-derived cell-free DNA tests and a blood gene-expression profile test in heart transplantation.
    Rodgers N; Gerding B; Cusi V; Vaida F; Tada Y; Morris GP; Adler ED; Stehlik J; Kim PJ
    Clin Transplant; 2023 Jun; 37(6):e14984. PubMed ID: 37036133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between donor-derived cell-free DNA and tissue-based rejection-related transcripts in heart transplantation.
    Lee DH; Usmani A; Wu R; Wicks T; Noh CY; Burke R; Ravichandran V; Wolf-Doty T; Dumitru I; Oliveira GH; Berman P; Mackie B
    J Heart Lung Transplant; 2024 Jul; 43(7):1118-1125. PubMed ID: 38373559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local laboratory-run donor-derived cell-free DNA assay for rejection surveillance in heart transplantation-first six months of clinical experience.
    Teszak T; Bödör C; Hegyi L; Levay L; Nagy B; Fintha A; Merkely B; Sax B
    Clin Transplant; 2023 Sep; 37(9):e15078. PubMed ID: 37489087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term clinical outcomes and predicted cost savings of dd-cfDNA-led surveillance after pediatric heart transplantation.
    Feingold B; Rose-Felker K; West SC; Miller SA; Zinn MD
    Clin Transplant; 2023 May; 37(5):e14933. PubMed ID: 36779524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining donor derived cell free DNA and gene expression profiling for non-invasive surveillance after heart transplantation.
    Henricksen EJ; Moayedi Y; Purewal S; Twiggs JV; Waddell K; Luikart H; Han J; Feng K; Wayda B; Lee R; Shudo Y; Jimenez S; Khush KK; Teuteberg JJ
    Clin Transplant; 2023 Mar; 37(3):e14699. PubMed ID: 35559582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The End of Endomyocardial Biopsy?: A Practical Guide for Noninvasive Heart Transplant Rejection Surveillance.
    Holzhauser L; DeFilippis EM; Nikolova A; Byku M; Contreras JP; De Marco T; Hall S; Khush KK; Vest AR
    JACC Heart Fail; 2023 Mar; 11(3):263-276. PubMed ID: 36682960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol-based donor-derived cell-free DNA surveillance in kidney transplant recipients: A single-center experience.
    Nissaisorakarn P; Patel H; Amtul A; Pavlakis M
    Clin Nephrol; 2022 Aug; 98(2):65-74. PubMed ID: 35445660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of donor-derived Cell-Free DNA in pediatric kidney transplant recipients: A single center study.
    Ranch D; Fei M; Kincade E; Piburn K; Hitchman K; Klein K
    Pediatr Transplant; 2024 Feb; 28(1):e14582. PubMed ID: 37550268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sparing the Prod: Providing an Alternative to Endomyocardial Biopsies With Noninvasive Surveillance After Heart Transplantation During COVID-19.
    Amadio JM; Rodenas-Alesina E; Superina S; Kozuszko S; Tsang K; Simard A; Aleksova N; Kobulnik J; Fan CS; Wijeysundera HC; Ross HJ; McDonald MA; Duero Posada JG; Moayedi Y
    CJC Open; 2022 May; 4(5):479-487. PubMed ID: 35187463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-specific patterns of donor-derived cell-free DNA in heart transplant rejection: An analysis from the Genomic Research Alliance for Transplantation (GRAfT).
    DeFilippis EM; Sweigart B; Khush KK; Shah P; Agbor-Enoh S; Valantine HA; Vest AR
    J Heart Lung Transplant; 2024 Jul; 43(7):1135-1141. PubMed ID: 38460620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter study.
    Khush KK; Patel J; Pinney S; Kao A; Alharethi R; DePasquale E; Ewald G; Berman P; Kanwar M; Hiller D; Yee JP; Woodward RN; Hall S; Kobashigawa J
    Am J Transplant; 2019 Oct; 19(10):2889-2899. PubMed ID: 30835940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-derived cell-free DNA (dd-cfDNA) for detection of allograft rejection in pediatric kidney transplants.
    Puliyanda DP; Swinford R; Pizzo H; Garrison J; De Golovine AM; Jordan SC
    Pediatr Transplant; 2021 Mar; 25(2):e13850. PubMed ID: 33217125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observed elevated donor-derived cell free DNA in orthotopic heart transplant recipients without clinical evidence of rejection.
    Afzal A; Alam A; van Zyl JS; Zafar H; Felius J; Hall SA; Carey SA
    Clin Transplant; 2022 Mar; 36(3):e14549. PubMed ID: 34863042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: A single-institution pilot study.
    Sorbini M; Togliatto GM; Simonato E; Boffini M; Cappuccio M; Gambella A; Arruga F; Mora N; Marro M; Caorsi C; Mansouri M; Magistroni P; Delsedime L; Papotti MG; Amoroso A; Rinaldi M; Vaisitti T; Deaglio S
    J Heart Lung Transplant; 2021 Aug; 40(8):794-804. PubMed ID: 34134912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial Differences in Donor-Derived Cell-Free DNA and Mitochondrial DNA After Heart Transplantation, on Behalf of the GRAfT Investigators.
    Shah P; Agbor-Enoh S; Lee S; Andargie TE; Sinha SS; Kong H; Henry L; Park W; McNair E; Tchoukina I; Shah KB; Najjar SS; Hsu S; Rodrigo ME; Jang MK; Marboe C; Berry GJ; Valantine HA;
    Circ Heart Fail; 2024 Apr; 17(4):e011160. PubMed ID: 38375637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.